The NHS GP explained what happens when you stop taking them(Image: Dr Amir Khan/Instagram) Dr Amir Khan has issued a fresh warning to anyone thinking of coming off weight-loss injections such as Wegovy or Mounjaro. The NHS GP…
Females using menopause hormone therapy (MHT) alongside GLP-1 medications such as Ozempic or Wegovy may experience greater weight loss, according to a study presented at the 2026 Annual Meeting of the Menopause Society. Weight gain is a common concern among middle-aged…
Sept 23 (Reuters) - Today we report on a real-world study that may help inform which drug is the best GLP-1 option for those with significant recent weight gain. We also cover a study in mice that sheds light on unanswered questions…
A pill version of the weight-loss medicine semaglutide attracted prescriptions unusually quickly after its launch, a US study reports. Its early growth was steeper than the initial uptake of two major injectable weight-management treatments. The finding concerns how rapidly a…
The European Medicines Agency’s committee recommended approval of Eli Lilly’s (LLY) weight-loss pill Foundayo on Friday, Reuters reports. It is the second oral obesity drug to get the agency’s backing, and Novo Nordisk’s Wegovy pill was first. The European Commission…
Metformin is widely used to lower blood sugar in type 2 diabetes, and research suggests it may also offer benefits beyond that main job. Its long history of use has also revealed side effects that range from digestive discomfort to less…
It is not known if Wegovy® injection is safe and effective: It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age. Do not use Wegovy® if: The most common side effects…
Eli Lilly and Company (LLY) moved a step closer to selling its Foundayo weight-loss pill in the European Union on October 16. That day, the European Medicines Agency announced that its human medicines committee recommends approval. The stock rose 0.43% to close…
The latest Oral GLP-1 Tracker from Fierce Pharma shows minor fluctuations for Foundayo and the Wegovy pill as the oral weight-loss drug market takes shape. Small swings in prescriptions and sales suggest the race between the two products remains tight.
Foundayo is on course to join Novo’s oral Wegovy in the European oral GLP-1RA market. A European Medicines Agency (EMA) panel has backed Eli Lilly’s Foundayo (orforglipron) for approval, helping the drugmaker close the gap on Novo Nordisk in the…
Oral weight-loss drugs: the Wegovy pill, orforglipron (Foundayo) and the next generation of obesity pills.
An article joins this feed when it matches these terms. Each one is also a search of its own.